Investigation of the possible influence of using blood pressure lowering drugs on plasma free metanephrines concentrations.

Completed

• Conditions: hypertensie; high blood pressure; hypertension; 10001353

• Registration Number: NL-OMON38391
• Lead Sponsor: niversitair Medisch Centrum Groningen

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 6 May 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 50

Inclusion Criteria

Untreated hypertension, periferal oedema, palpitations or migrain.

Exclusion Criteria

Treated hypertension.
Normal or low blood pressure. If there is no indication to start with -blocker, ACE-inhibitors or diuretics.

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Free metanephrines (i.e. metanefrine, normetanefrine en 3-methoxytyramine) are<br /><br>measured in plasma.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Nvt</p><br>